Virbac S.A.
VIRP
Rank in Stocks
#4513
Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent... Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North America, Asia Pacific, the Middle East, and Africa, catering to both domestic companion animals and commercial livestock. Its extensive portfolio encompasses vaccines, dental hygiene products, reproductive health solutions, dermatological treatments, parasiticides, diagnostic instruments, antibiotics, and aquaculture offerings. Furthermore, Virbac supplies specialized veterinary pharmaceuticals for anesthesia, geriatric care, behavioral management, and injectable micronutrients, alongside pet food and electronic identification systems. These diverse solutions are designed to support veterinarians, agricultural producers, and individual pet owners worldwide.
Share Price
$408.63
Last synced: 2026-10-20
Market Cap
$3.42B
Change (1 day)
2.23%
Change (1 year)
-0.91%
Country
FR
Trade Virbac S.A. (VIRP)
Category
Healthcare
P/E ratio for Virbac S.A. (VIRP)
P/E ratio as of October 2026 TTM: 18.15
According to Virbac S.A. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 18.15. At the end of 2023 the company had a P/E ratio of 24.62.
P/E ratio history for Virbac S.A. from 2002 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 18.15 | -0.56% |
| 2024 | 18.25 | -25.86% |
| 2023 | 24.62 | 55.88% |
| 2022 | 15.79 | -50.16% |
| 2021 | 31.69 | 114.69% |
| 2020 | 14.76 | -61.84% |
| 2019 | 38.68 | -18.88% |
| 2018 | 47.69 | -111.86% |
| 2017 | -401.94 | -1,088.09% |
| 2016 | 40.68 | -79.35% |
| 2015 | 197.02 | 752.74% |
| 2014 | 23.10 | 6.84% |
| 2013 | 21.62 | 14.19% |
| 2012 | 18.94 | 9.87% |
| 2011 | 17.24 | -1.63% |
| 2010 | 17.52 | 10.20% |
| 2009 | 15.90 | 15.61% |
| 2008 | 13.75 | -25.93% |
| 2007 | 18.57 | 13.73% |
| 2006 | 16.33 | -4.26% |
| 2005 | 17.05 | 31.48% |
| 2004 | 12.97 | 39.91% |
| 2003 | 9.27 | 50.06% |
| 2002 | 6.18 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 40.53 | 123.33% |
US
|
|
| 38.50 | 112.13% |
US
|
|
| 79.88 | 340.16% |
US
|
|
| 116.96 | 544.48% |
US
|
|
| 22.25 | 22.60% |
CH
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.